causal
Biotech Faces High Barriers to Entry and Scale
Unlike cosmetics, where a product can scale through a distributor like L'Oreal, health care has high barriers to both entry and scale, which makes the hurdle even higher and the sector more interesting to investors.
causalpending
Speaker
MattEvidence Quote
“Here, it's high barrier to entry and high barrier to scale.”
Created: 11/13/2026, 1:54:32 PM
Your notes
Loading notes...